Table 1 The percentages of chronic diseases, signs and symptoms and chronic medications in the entire group and in survivors and non-survivors
Entire group (n=163) | Survivors (n=139) | Non-survivors (n=24) | p value* | |
|---|---|---|---|---|
Diseases (% affected) | ||||
Depression | 5.6 | 5.1 | 8.3 | 0.53 |
Immune disease | 1.2 | 0.7 | 4.2 | 0.16 |
Liver disease | 6.9 | 6.7 | 8.3 | 0.77 |
Cancer past | 7.5 | 6.6 | 12.5 | 0.71 |
Cancer current | 6.2 | 4.4 | 16.7 | 0.02 |
Thyroid disease | 17.9 | 16.7 | 25.0 | 0.33 |
Chronic kidney disease | 6.3 | 3.7 | 20.8 | 0.001 |
Venous thromboembolism | 5.6 | 5.8 | 4.2 | 0.74 |
Peripheral arterial disease | 10.1 | 9.0 | 16.7 | 0.25 |
Diabetes mellitus | 35.4 | 30.7 | 62.5 | 0.003 |
Hypertension | 82.6 | 81.9 | 87.0 | 0.55 |
Stroke | 5.6 | 3.7 | 17.4 | 0.008 |
Atrial fibrillation | 18.8 | 16.2 | 33.3 | 0.05 |
Heart failure | 12.2 | 9.0 | 31.8 | 0.002 |
Myocardial infarction | 17.1 | 12.6 | 43.5 | 0.0003 |
Coronary heart diseases | 29.0 | 25.0 | 52.2 | 0.008 |
Chronic obstructive pulmonary disease | 9.3 | 8.0 | 16.7 | 0.18 |
Asthma | 9.3 | 8.0 | 16.7 | 0.18 |
Signs and symptoms (% affected) | ||||
Tachypnea | 16.9 | 13.7 | 22.7 | 0.01 |
Oedema | 5.8 | 5.4 | 8.7 | 0.52 |
Diarhorrea | 31.2 | 31.8 | 27.3 | 0.67 |
Nausea/vomiting | 17.5 | 17.4 | 18.2 | 0.93 |
Chest pain | 18.2 | 18.2 | 18.2 | 1.00 |
Skin leasions | 3.3 | 3.0 | 4.6 | 0.71 |
Back pain | 34.4 | 36.4 | 22.7 | 0.22 |
Muscular pain | 44.8 | 47.7 | 27.3 | 0.07 |
Malaise | 86.4 | 87.1 | 81.8 | 0.50 |
Headache | 37.0 | 37.9 | 31.8 | 0.59 |
Running nose | 16.9 | 16.7 | 18.2 | 0.86 |
Sore throat | 19.5 | 17.4 | 31.8 | 0.12 |
Ageusia | 16.9 | 15.9 | 22.7 | 0.43 |
Anosmia | 16.2 | 15.2 | 22.7 | 0.37 |
Dyspnoe | 74.0 | 72.0 | 86.4 | 0.15 |
Cough | 70.8 | 72.0 | 63.6 | 0.43 |
Shivers | 44.8 | 48.5 | 22.7 | 0.02 |
Fever | 75.3 | 75.8 | 72.7 | 0.76 |
Subfebrile | 58.4 | 60.6 | 45.5 | 0.18 |
Asymptomatic | 6.0 | 5.5 | 9.5 | 0.47 |
Medications (% taking) | ||||
Vitamin D | 24.4 | 25.4 | 18.2 | 0.47 |
Proton-pump inhibitors | 19.9 | 18.8 | 26.1 | 0.42 |
Inhaled non-steroid drugs | 14.3 | 13.8 | 17.4 | 0.65 |
Inhaled steroid drugs | 11.1 | 9.4 | 20.8 | 0.10 |
Non-steroidal anti-inflammatory drugs | 28.3 | 28.7 | 26.1 | 0.80 |
Antidepressants | 7.4 | 5.8 | 16.7 | 0.06 |
Neuroleptics | 1.2 | 0.7 | 4.4 | 0.15 |
Insulin | 9.3 | 6.5 | 26.1 | 0.003 |
Sulphonylureas | 11.9 | 11.0 | 17.4 | 0.38 |
Flosin | 1.3 | 0.7 | 4.4 | 0.15 |
Metformin | 26.9 | 23.4 | 47.8 | 0.01 |
Non-vitamin K antagonist oral anticoagulants | 11.1 | 9.4 | 20.8 | 0.10 |
Vitamin K antagonists | 5.0 | 3.7 | 12.5 | 0.07 |
Aspirin | 29.0 | 25.4 | 50.0 | 0.01 |
Statins | 40.3 | 39.0 | 47.8 | 0.42 |
Alfa-blockers | 14.7 | 13.4 | 21.7 | 0.30 |
Mineralocorticoid receptor antagonists | 6.4 | 4.5 | 17.4 | 0.02 |
Calcium channel blockers | 28.0 | 29.1 | 21.7 | 0.47 |
Diuretics | 46.5 | 44.8 | 56.5 | 0.30 |
Beta-blockers | 59.9 | 56.7 | 78.3 | 0.05 |
Angiotensin receptor blocker | 18.5 | 18.7 | 17.4 | 0.89 |
Angiotensin-converting enzyme inhibitors | 45.5 | 44.4 | 52.2 | 0.49 |